Prevention and control of COVID-19

Information on how to protect yourself and others from COVID-19, including risk groups, vaccines, contact tracing and non-pharmaceutical interventions.

COVID-19 vaccination

COVID-19 vaccines are being developed following the same legal requirements for quality, safety and efficacy as for all other vaccines.

Efficacy, effectiveness and safety of vaccines against COVID-19

A living systematic review on the efficacy, effectiveness and safety of COVID-19 vaccines authorised in the EU/EEA

Non-pharmaceutical interventions

After vaccination, non-pharmaceutical interventions are the most effective public health interventions against COVID-19.

Contact tracing

Contact tracing remains a key tool to break transmission chains of COVID-19.

Guidance on quarantine and isolation

This guidance aims to provide options for adapting quarantine and isolation particularly when countries face high or extreme pressure on healthcare systems and other functions in society, including essential services.

How to protect yourself

How to protect yourself and others from infection with COVID-19?

Risk groups

High-risk groups for COVID-19 are people aged 60 years and older; those living in long-term care facilities; and people with underlying health conditions.

Patient and case management

ECDC resources on patient and case management for COVID-19: patient and case management, protective equipment, diagnosis, prevention, vaccines.

Long-term care facilities

The Response Measures Database (RMD)

The ECDC-JRC database is an archive of non-pharmaceutical interventions (NPIs), or measures, introduced by 30 countries in the European Union and European Economic Area in response to the coronavirus disease (COVID-19) pandemic. The RMD is reviewed and updated every two weeks.

Data

Social contact patterns in the EU/EEA during the COVID-19 pandemic

Data - 27 Sep 2022

This survey (CoMix) was conducted to enhance our understanding of contact mixing during the transition period beyond the acute phase of the COVID-19 pandemic.

Featured links

Latest

Featured links

Latest

Featured links

Latest

Featured links

Spotlight

Featured links

Spotlight

Prevention and control of COVID-19

COVID-19 vaccination

Efficacy, effectiveness and safety of vaccines against COVID-19

Non-pharmaceutical interventions

Contact tracing

Guidance on quarantine and isolation

How to protect yourself

Risk groups

Patient and case management

Long-term care facilities

Read more

The Response Measures Database (RMD)

Social contact patterns in the EU/EEA during the COVID-19 pandemic

All reports on prevention and control

Data collection on COVID-19 outbreaks in closed settings: long-term care facilities, version 2.1

Guidance on ending the isolation period for people with COVID-19, third update

Surveillance of COVID-19 in long-term care facilities in the EU/EEA

Contact tracing in the European Union: public health management of persons, including healthcare workers, who have had contact with COVID-19 cases – fourth update

Rapid Risk Assessment: COVID-19 outbreaks in long-term care facilities in the EU/EEA in the context of current vaccination coverage

Considerations for the use of face masks in the community in the context of the SARS-CoV-2 Omicron variant of concern

Threat Assessment Brief: Implications of the further emergence and spread of the SARS-CoV-2 B.1.1.529 variant of concern (Omicron) for the EU/EEA - first update

Contact tracing in the European Union: public health management of persons, including healthcare workers, who have had contact with COVID-19 cases – fourth update

COVID-19 in children and the role of school settings in transmission - second update

Considerations for the use of saliva as sample material for COVID-19 testing

COVID-19 Aviation Health Safety Protocol: Operational guidelines for the management of air passengers and aviation personnel in relation to the COVID-19 pandemic

Threat Assessment Brief: Implications of the further emergence and spread of the SARS-CoV-2 B.1.1.529 variant of concern (Omicron) for the EU/EEA - first update

Threat Assessment Brief: Implications of the emergence and spread of the SARS-CoV-2 B.1.1. 529 variant of concern (Omicron) for the EU/EEA

Assessment of the current SARS-CoV-2 epidemiological situation in the EU/EEA, projections for the end-of-year festive season and strategies for response, 17th update

Communicable disease threats report, 6 - 12 June 2021, week 23

Generic protocol for COVID-19 vaccine effectiveness studies at long-term care facilities in the EU/EEA

Surveillance of COVID-19 in long-term care facilities in the EU/EEA

Guidance on the provision of support for medically and socially vulnerable populations in EU/EEA countries and the United Kingdom during the COVID-19 pandemic

Infection prevention and control and surveillance for coronavirus disease (COVID-19) in prisons in EU/EEA countries and the UK

COVID-19 in reception and detention centres for migrants and refugees

Conducting after-action reviews of the public health response to COVID-19: update

ECDC expert consultation on knowledge and research gaps related to the COVID-19 public health response

Assessing the Implementation of Digital Innovations in Response to the COVID-19 Pandemic to Address Key Public Health Functions: Scoping Review of Academic and Nonacademic Literature

Multisystem Inflammatory Syndrome in Children (MIS-C)

Considerations for the use of antibody tests for SARS-CoV-2 – first update

More on this topic

Preparedness for COVID-19

Follow us: